Description
Peptide B is a fibrinogen-like peptide that acts as a vascular vasoconstrictor. In vivo, it exhibits hemostatic activity, decreasing bleeding time. Peptide B also accelerates effects associated with superprecipitation of myosin B.
Peptide B is a fibrinogen-like peptide that acts as a vascular vasoconstrictor. In vivo, it exhibits hemostatic activity, decreasing bleeding time. Peptide B also accelerates effects associated with superprecipitation of myosin B.
| Purity | ≥95% |
|---|---|
| Formula | C98H145N25O26S2 |
| Formula Wt. | 2153.49 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Nichols WW, Mehta J, Wargovich T, et al. Fibrin(ogen)-derived peptide B beta 30-43 increases coronary blood flow in the anesthetized dog. Thromb Res. 1985 Jul 15;39(2):223-9. PMID: 3895564.
Osbahr AJ, Custodio R. Action of peptide-B from bovine fibrinogen on ATPase activity and superprecipitation of myosin B. Am J Physiol. 1975 Feb;228(2):488-95. PMID: 123418.
Osbahr AJ. The hemostatic effect of bovine peptide-B from fibrinogen. Thromb Diath Haemorrh. 1974 Sep 30;32(1):149-56. PMID: 4454037.
Proteinase subtrate.
Endogenous glycoprotein; lactoferrin agonist.
Endogenous bombesin-related peptide, involved i...
Endogenous peptide hormone; CCK2 agonist, indir...
Dihydropyridine; L-type Ca2+ channel blocker.
Peptide; serine protease inhibitor.
VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
Integrase inhibitor.
Ca2+ ionophore.
Topoisomerase II inhibitor, RPA modulator.
Active metabolite of losartan
Synthetic somatostatin analog, peptide; somatos...
Endogenous tachykinin peptide, involved in infl...
Fibrate; PPARα agonist.
Phthalide; PPARγ agonist, IMPDH inhibitor, mic...
Inhibitor of VEGFR and FGFR.
FIASMA, 5-HT1/2, M1-5 mAChR, α1-adrenergic, hi...
Inert clozapine analog, activates specialized G...
May be useful against COVID-19
Valsartan impurity